Perception and willingness toward second-generation long-acting antipsychotics among patients with schizophrenia: a cross-sectional survey in Fujian, China
Frontiers in Psychiatry · 14.07.2026 · 17
DOI: 10.3389/fpsyt.2026.1841818 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Frontiers in Psychiatry, online erschienen am 14.07.2026. Verfasst von Yixiang Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xiamen Xianyue Hospital, Xiamen, China. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To assess perceptions and willingness toward second-generation antipsychotic long-acting injectables (SGA-LAIs) among patients with schizophrenia, to identify the influencing factors, and to provide evidence for optimizing clinical implementation strategies.
Methods
A cross-sectional survey was conducted in which patients with schizophrenia who attended outpatient follow-up visits at a tertiary psychiatric hospital were recruited via convenience sampling. A validated, expert-reviewed questionnaire was administered. Data were analyzed using descriptive statistics and chi-square tests, with binary logistic regression models employed to explore the determinants of patients’ willingness to accept SGA-LAIs.
Results
The sample characteristics included 126 males (55.5%), 114 patients (50.2%) aged 31–50 years, 140 patients (61.7%) with an illness course exceeding 5 years, and 126 patients (55.5%) with experience with SGA-LAIs. Overall, 155 participants (68.3%) expressed positive willingness to use SGA-LAIs, whereas 72 participants (31.7%) expressed negative willingness. Univariate analysis revealed significant differences between the willingness-positive and willingness-negative groups in terms of disease course (χ² = 12.314, P = 0.006) and prior SGA-LAI experience (χ² = 55.525, P < 0.001). Binary logistic regression analysis revealed that patients with prior SGA-LAI experience (OR = 11.11, 95% CI: 5.41~23.26, P < 0.001), a disease course of 5–10 years (OR = 2.898, 95% CI: 1.134-7.407, P = 0.026), and a disease course of > 10 years (OR = 3.282, 95% CI: 1.300-8.288, P = 0.012) demonstrated significantly greater willingness to accept SGA-LAIs. Among the willingness-positive group, the most endorsed advantages of SGA-LAIs were “avoiding daily medication” (80.7%) and “increased effectiveness” (68.4%), and the primary concern was “injection pain” (56.8%). In the willingness-negative group, the predominant reasons for refusal were “rejection of needles” (93.1%) and “rejection of changing therapeutic regimens” (79.2%).
Conclusion
The overall acceptance of and willingness to use SGA-LAIs among patients with schizophrenia followed up in psychiatric hospitals are high. Experience with SGA-LAIs and disease course were identified as independent factors influencing patients’ willingness to use SGA-LAIs. In clinical practice, patient acceptance can be enhanced by strengthening doctor-patient communication, prioritizing medication education for patients with a long disease course, and improving patients’ initial experience with SGA-LAIs, thereby supporting broader clinical adoption of SGA-LAIs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Xiamen Xianyue Hospital, Xiamen, China.
- Xianyue Hospital Affiliated with Xiamen Medical College, Xiamen, China.
- Fujian Psychiatric Center, Xiamen, China.
- Fujian Clinical Research Center for Mental Disorders, Xiamen, China.
- Department of Psychiatry, Xiamen Xianyue Hospital, Xiamen, China.
Zitieren
APA
Zhou, Y., Lin, D., Zhang, H., & Huang, Y. (2026). Perception and willingness toward second-generation long-acting antipsychotics among patients with schizophrenia: a cross-sectional survey in Fujian, China. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1841818
Vancouver
Zhou Y, Lin D, Zhang H, Huang Y. Perception and willingness toward second-generation long-acting antipsychotics among patients with schizophrenia: a cross-sectional survey in Fujian, China. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1841818
BibTeX
@article{Zhou2026,
author = {Zhou, Yixiang and Lin, Duoduo and Zhang, Haibin and Huang, Yinghua},
title = {Perception and willingness toward second-generation long-acting antipsychotics among patients with schizophrenia: a cross-sectional survey in Fujian, China},
journal = {Frontiers in Psychiatry},
year = {2026},
volume = {17},
doi = {10.3389/fpsyt.2026.1841818}
}
EUVIMED